Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients

Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients

The purpose of this study is to determine the safety and IOP-lowering ability of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension.

Inclusion Criteria:

• 18 years or older.
• Diagnosis of open-angle glaucoma or ocular hypertension.
• LogMAR visual acuity not worse than 0.6.
• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Clinically relevant ophthalmic or systemic conditions.
• Other protocol-defined exclusion criteria may apply.